Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Bunnage Mark E.
EVP, Chief Scientific Officer at Vertex Pharmaceuticals. Filing since 11 Feb 2026.
CIK 0002100735
Company
Date
Role
Action
Shares
Amount
Of holding
VRTX
Vertex Pharmaceuticals
15 May 2026
EVP, Chief Scientific Officer
Sold on a plan
33
$14.96K
0.5%
VRTX
Vertex Pharmaceuticals
25 Feb 2026
EVP, Chief Scientific Officer
Sold on a plan
620
$301.54K
7.8%
VRTX
Vertex Pharmaceuticals
18 Feb 2026
EVP, Chief Scientific Officer
Sold on a plan
1,182
$559.89K
12.2%
VRTX
Vertex Pharmaceuticals
17 Feb 2026
EVP, Chief Scientific Officer
Sold on a plan
2,437
$1.19M
20.1%
VRTX
Vertex Pharmaceuticals
11 Feb 2026
EVP, Chief Scientific Officer
Sold on a plan
2,021
$930.53K
13.5%
5 decisions on file.
